LD-2 disclosure · 3rd Quarter - Report
ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)
Client
- Name
- ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)
- Location
- Delaware · United States of America
Registrant
- Description
- Lobbying Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesMedicare/Medicaid
Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Payment policies for Medicare Part B Prescription drugs; Independent Payment Advisory Board (IPAB), repeal of Part D Non-interference Provision; CCMI Medicare Part B Demonstration.
LobbyistsSUSAN HIRSCHMANN · mr JACK STEVEN HART · GEORGE OLSEN · KARINA LYNCH · mr MATTHEW B HOEKSTRA · CHERYL LYNN JAEGER · ERIN BOOK MULLEN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of the Vice President of the United States
Taxation/Internal Revenue Code
Tax issues affecting the pharmaceutical industry, tax reform issues.
LobbyistsGEORGE OLSEN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of the Vice President of the United States
Health Issues
21st Century Cures Initiative (House Energy and Commerce Committee) and Innovations for Healthier Americans (Senate Health, Education, Labor and Pensions Committee); possible drug provisions in FY 2017 appropriations bills; Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Senate Finance Committee Chronic Disease Initiative; Implementation of Precision Medicine Initiative; White House Cancer Moonshot; Legislation affecting the ESRD program.